Medical prfessional looking at test tubes

Archimedes Pharma - Company

About Archimedes Pharma

Archimedes Pharma is an international specialty pharmaceutical company providing novel and advanced treatments to address unmet needs for people living with serious or life–threatening chronic and debilitating illnesses. Marketing a diverse portfolio of specialty products focused on the oncology, pain, and critical care sectors, Archimedes Pharma has operations in the US and throughout Europe.

Founded in 2004, Archimedes Pharma initially acquired a range of specialty products and technologies together with a commercial pharmaceutical platform to establish itself in the European market. Since then the company has expanded its operations to include the in–house development of products based on its proprietary drug delivery technologies and establishing commercial operations in the US.

In 2010, Archimedes Pharma attracted significant additional investment to further the company’s growth strategies and build an experienced leadership team, raising approximately $100 million in capital – the largest amount raised by a private European biopharmaceutical company in the past 15 years.

Archimedes Pharma is currently focused on the launch of its lead product, Lazanda® (fentanyl nasal spray) / PecFent® (fentanyl pectin nasal spray) for the management of breakthrough pain in cancer patients, in the US and across Europe. Breakthrough pain in cancer (BTPc) is characterized by sudden, often unpredictable episodes of intense pain that may last up to 60 minutes and occur despite background pain medication. On average, more than half of patients with cancer experience breakthrough pain.

Archimedes Pharma has a strong commitment to patients and its customers. By providing novel and technologically advanced therapies, Archimedes Pharma looks to improve current therapeutic approaches and enhance care to patients.

Download our Company Fact Sheet

Key Facts

  • Privately Held
  • Founded: 2004
  • CEO: Jeffrey H. Buchalter
  • Locations:
    • HQ: Reading, England
    • U.S. Operations: Bedminster, New Jersey
    • EU Operations: UK, France, Germany, Spain, and Ireland
  • 250+ Employees
  • Sales: Company generates multi–million dollars in revenue from multiple commercialized products.

Archimedes Pharma’s principal products include: